Represents the interests of the international research-based pharmaceutical industry
main activity is to ensure that the views and interests of the
international research-based pharmaceutical industry are recognised by
those institutions, at home and abroad, who are involved in
pharmaceutical and healthcare matters.
Builds relationships with other partners in healthcare
maintains regular contacts with all relevant institutions in and
outside Ireland, e.g. Department of Health and related
agencies like the Health Products Regulatory Authority (formerly the
Irish Medicines Board), the Health Service Executive, the Primary Care
Rimbursement Service, relevant healthcare professional organisations,
the European Commission, the European Parliament, the EFPIA, the AESGP and the IFPMA.
Participates in the healthcare decision making process
is regularly consulted in draft decisions made for example by the
Department of Health & Children and other Government agencies which
relate to pharmaceutical and health matters.
Ensures the highest possible standards of advertising and promotion
IPHA also administers a number of Codes of Practice including the Code of Marketing Practice for the Pharmaceutical Industry and the Code of Advertising Standards for the Consumer Healthcare Industry. The objective of these Codes is to ensure the highest possible standards in the promotion and advertising of medicines.
Keeps the healthcare professions up-to-date
IPHA publishes www.medicines.ie - medicines information online
- and distributes a version every year free of charge, to members of
the medical and pharmacy professions. IPHA members are committed to
supporting the continuing medical education of healthcare professionals
and they invest heavily every year in many such programmes.
Ensures supply of the full range of innovative medicines
pricing continues to be a sensitive and difficult issue. In recognition
of the funding difficulties faced by the State and in order to meet the
objective of providing the full range of modern therapeutically
advanced medicines to all patients regardless of income, the members of
IPHA have entered into a binding Agreement with the Health Service Executive to provide the best possible value for money in relation to the purchasing of medicines for the health services in Ireland.